Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
221.6 USD | -3.69% |
|
-2.85% | -14.37% |
12:26pm | Goldman Sachs Adjusts Price Target on Biogen to $342 From $340, Maintains Buy Rating | MT |
09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.37% | 32.26B | |
+7.40% | 101B | |
+7.76% | 42.18B | |
+81.05% | 29.79B | |
-12.27% | 16.06B | |
+2.33% | 14.45B | |
-8.56% | 12.01B | |
+182.74% | 10.71B | |
+4.27% | 8.89B | |
-56.23% | 8.83B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Tranche Update on Biogen Inc.'s Equity Buyback Plan announced on March 25, 2019.